Ligand Pharmac-B

LGND

294.9902.81% ( -8.540 )

Closed: Oct 14, 15:59:59 (EDT)

Current ValuationThe current P/E ratio is 30.68, within the reasonable range, cheaper than 49.1% of the time in the past 3 years, and the industry ranks 46/255, the industry Median -1.22.

30.68xP/E

Stock price$303.53Earnings per share$9.89

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
PFEUSPfizer	37.31x	16.40%	$161.70B
AMRXUSAmneal Pharmaceuticals	39.72x	121.20%	$6.25B
LGNDUSLigand Pharmac-B	30.68x	14.77%	$6.05B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.